Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J. 2003;24:1710–8.
PubMed
Article
CAS
Google Scholar
Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655–63.
PubMed
Article
CAS
Google Scholar
Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation. 2009;120:2177–87.
PubMed
Article
CAS
Google Scholar
Struthers A, Lang C. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent ‘pancardiac’ target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur Heart J. 2007;28:1678–82.
PubMed
Article
CAS
Google Scholar
McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 2001;86:21–6.
PubMed
Article
CAS
Google Scholar
Otsuka T, Kawada T, Seino Y, Ibuki C, Katsumata M, Kodani E. Relation of smoking status to serum levels of N-terminal pro-brain natriuretic peptide in middle-aged men without overt cardiovascular disease. Am J Cardiol. 2010;106:1456–60.
PubMed
Article
CAS
Google Scholar
Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594–600.
PubMed
Article
CAS
Google Scholar
Pfister R, Sharp S, Luben R, Welsh P, Barroso I, Salomaa V, et al. Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Med. 2011;8:e1001112.
PubMed
Article
CAS
Google Scholar
Wannamethee SG, Welsh P, Lowe GD, Gudnason V, Di Angelantonio E, Lennon L, et al. N-terminal pro-brain natriuretic peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol. 2011;58:56–64.
PubMed
Article
CAS
Google Scholar
Radvan M, Svoboda P, Radvanova J, Stumar J, Scheer P. Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients. Hepatogastroenterology. 2009;56:181–5.
PubMed
CAS
Google Scholar
Yildiz R, Yildirim B, Karincaoglu M, Harputluoglu M, Hilmioglu F. Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol. 2005;20:1115–20.
PubMed
Article
CAS
Google Scholar
Hofer P, Syeda B, Bergler-Klein J, Friedrich F, Lesch OM, Vyssoki B, et al. Amino-terminal pro-B-type brain natriuretic peptide: screening for cardiovascular disease in the setting of alcoholism. Alcohol Alcohol. 2011;46:247–52.
PubMed
Article
Google Scholar
Ljubicic N, Gomercic M, Zekanovic D, Bodrozic-Dzakic T, Djuzel A. New insight into the role of NT-proBNP in alcoholic liver cirrhosis as a noninvasive marker of esophageal varices. Croat Med J. 2012;53:374–8.
PubMed
Article
CAS
Google Scholar
Roerecke M, Greenfield TK, Kerr WC, Bondy S, Cohen J, Rehm J. Heavy drinking occasions in relation to ischaemic heart disease mortality–an 11–22 year follow-up of the 1984 and 1995 US national alcohol surveys. Int J Epidemiol. 2011;40:1401–10.
PubMed
Article
Google Scholar
Klatsky AL. Alcohol and cardiovascular health. Physiol Behav. 2010;100:76–81.
PubMed
Article
CAS
Google Scholar
Sull JW, Yi SW, Nam CM, Choi K, Ohrr H. Binge drinking and hypertension on cardiovascular disease mortality in Korean men and women: a Kangwha cohort study. Stroke. 2010;41:2157–62.
PubMed
Article
Google Scholar
Shestov DB, Deev AD, Klimov AN, Davis CE, Tyroler HA. Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian lipid research clinics prevalence follow-up study. Circulation. 1993;88:846–53.
PubMed
Article
CAS
Google Scholar
Averina M, Nilssen O, Brenn T, Brox J, Kalinin AG, Arkhipovsky VL. High cardiovascular mortality in Russia cannot be explained by the classical risk factors. The Arkhangelsk Study 2000. Eur J Epidemiol. 2003;18:871–8.
PubMed
Article
Google Scholar
Roberts B, Stickley A, Balabanova D, Haerpfer C, McKee M. The persistence of irregular treatment of hypertension in the former Soviet Union. J Epidemiol Community Health. 2012;66:1079–82.
Google Scholar
Pomerleau J, Gilmore A, McKee M, Rose R, Haerpfer CW. Determinants of smoking in eight countries of the former Soviet Union: results from the living conditions, lifestyles and health study. Addiction. 2004;99:1577–85.
PubMed
Article
Google Scholar
Leon DA, Chenet L, Shkolnikov VM, Zakharov S, Shapiro J, Rakhmanova G, et al. Huge variation in Russian mortality rates 1984–1994: artefact, alcohol, or what? Lancet. 1997;350:383–8.
PubMed
Article
CAS
Google Scholar
Leon DA, Shkolnikov VM, McKee M, Kiryanov N, Andreev E. Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause? Int J Epidemiol. 2010;39:1279–90.
PubMed
Article
Google Scholar
Leon DA, Saburova L, Tomkins S, Andreev E, Kiryanov N, McKee M, et al. Hazardous alcohol drinking and premature mortality in Russia: a population based case-control study. Lancet. 2007;369:2001–9.
PubMed
Article
Google Scholar
Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48, 557 adult deaths. Lancet. 2009;373:2201–14.
PubMed
Article
CAS
Google Scholar
McKee M, Britton A. The positive relationship between alcohol and heart disease in Eastern Europe: potential physiological mechanisms. J R Soc Med. 1998;91:402–7.
PubMed
CAS
Google Scholar
Leon DA, Shkolnikov VM, McKee M. Alcohol and Russian mortality: a continuing crisis. Addiction. 2009;104:1630–6.
PubMed
Article
Google Scholar
Yarnell JW. The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective epidemiological study of myocardial infarction. QJM. 1998;91:667–76.
PubMed
Article
CAS
Google Scholar
Tomkins S, Collier T, Oralov A, Saburova L, McKee M, Shkolnikov V, et al. Hazardous alcohol consumption is a major factor in male premature mortality in a typical Russian city: prospective cohort study 2003–2009. PLoS One. 2012;7:e30274.
PubMed
Article
CAS
Google Scholar
Persijn JP, van der SW, Zwart WA. Colorimetric assay for -glutamyl transpeptidase. Clin Chim Acta. 1971;35:239–40.
PubMed
Article
CAS
Google Scholar
Vector-Best product catalogue. http://vector-best.ru/ (2012). Accessed 16 Feb 2012.
Schellenberg F, Wielders JP. Evaluation of capillary electrophoresis assay for CDT on SEBIA’s capillarys system: intra and inter laboratory precision, reference interval and cut-off. Clin Chim Acta. 2010;411:1888–93.
PubMed
Article
CAS
Google Scholar
Muthén B. Latent variable structural equation modeling with categorical data. J Econom. 1983;22:43–65.
Article
Google Scholar
Muthén LK, Muthén BO. Mplus user’s guide. 4th ed. Los Angeles: Muthén & Muthén; 2006.
Google Scholar
StataCorp. Stata statistical software: release 11. College station, TX: StataCorp LP; 2009.
Chen L, Davey Smith G, Harbord RM, Lewis SJ. Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach. PLoS Med. 2008;5:e52.
PubMed
Article
Google Scholar
Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. Br Med J. 2011;342:d636.
Article
Google Scholar
Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet. 1977;2:153–5.
PubMed
Article
CAS
Google Scholar
Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the lipid research clinics follow-up study. Am J Epidemiol. 1987;126:629–37.
PubMed
CAS
Google Scholar
Muth ND, Laughlin GA, von Muhlen D, Smith SC, Barrett-Connor E. High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: the Rancho Bernardo study. Br J Nutr. 2010;104:1034–42.
PubMed
Article
CAS
Google Scholar
Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, et al. Lipid-related markers and cardiovascular disease prediction. JAMA. 2012;307:2499–506.
PubMed
Article
CAS
Google Scholar
Briel M, Ferreira-Gonzalez I, You JJ, Karanicolas PJ, Akl EA, Wu P, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. Br Med J. 2009;338:b92.
Article
Google Scholar
Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012. doi:10.1016/S0140-6736(12)60312-2.
Perova NV, Oganov RG, Williams DH, Irving SH, Abernathy JR, Deev AD, et al. Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men. Ann Epidemiol. 1995;5:179–85.
PubMed
Article
CAS
Google Scholar
Averina M, Nilssen O, Brenn T, Brox J, Arkhipovsky VL, Kalinin AG. Factors behind the increase in cardiovascular mortality in Russia: apolipoprotein AI and B distribution in the Arkhangelsk study 2000. Clin Chem. 2004;50:346–54.
PubMed
Article
CAS
Google Scholar
Popova S, Rehm J, Patra J, Zatonski W. Comparing alcohol consumption in central and Eastern Europe to other European countries. Alcohol Alcohol. 2007;42:465–73.
PubMed
Article
Google Scholar
McKee M, Szucs S, Sarvary A, Adany R, Kiryanov N, Saburova L, et al. The composition of surrogate alcohols consumed in Russia. Alcohol Clin Exp Res. 2005;29:1884–8.
PubMed
Article
Google Scholar
Solodun YV, Monakhova YB, Kuballa T, Samokhvalov AV, Rehm J, Lachenmeier DW. Unrecorded alcohol consumption in Russia: toxic denaturants and disinfectants pose additional risks. Interdiscip Toxicol. 2012;4:101–8.
Google Scholar
Gil A, Polikina O, Koroleva N, McKee M, Tomkins S, Leon DA. Availability and characteristics of nonbeverage alcohols sold in 17 Russian cities in 2007. Alcohol Clin Exp Res. 2009;33:79–85.
PubMed
Article
Google Scholar
Vikhert AM, Tsiplenkova VG, Cherpachenko NM. Alcoholic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 1986;8:3A–11A.
PubMed
Article
CAS
Google Scholar